Torsemide

Torsemide is a loop diuretic, a medicine taken by mouth that acts on the kidney. The US label read, for a generic torsemide tablet, lists swelling from fluid build-up in people with heart failure, kidney disease or liver disease, and the lowering of blood pressure in people with high blood pressure. The label also says there are no controlled trials demonstrating risk reduction with torsemide.

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 38413; UNII W31X2H97FB. MeSH descriptor D000077786 is Torsemide. Class: Loop Diuretic (FDA established pharmacologic class, RxClass). The label read is a generic product, not a brand label: the Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. torsemide tablet label, application ANDA076894, effective 2023-06-30 in openFDA. openFDA has no brand-name torsemide label with full text; the Soaanz record (NDA213218) carries no label sections, and the Drugs@FDA applications NDA020136 and NDA020137 have no openFDA label. Other generic labels and repackager labels were not read. This page records label indications, the mechanism sentence and the class only: no trial result and no dose is given.

About this drug

Level
Substance
Mechanism
The label says torsemide acts in the thick ascending part of the loop of Henle in the kidney.

Claims and evidence

Context Patients with edema, and patients with hypertension, as described in the US label of generic torsemide tablets

Recipient
Recipient not specified
Population
Patients described in the indications section of the label: people with edema associated with heart failure, renal disease or hepatic disease, and people with hypertension. The label passages read do not state an age range.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Not stated in the label passages read
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (label statement)
Eligibility: 2 inclusion criteria; exclusion criteria not stated
Included
  • Patients with edema associated with heart failure, renal disease or hepatic disease
  • Patients with hypertension
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of generic torsemide tablets (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., application ANDA076894; the version dated 2023-06-30 in openFDA) describes torsemide as a loop diuretic. It lists the treatment of edema associated with heart failure, renal disease or hepatic disease, and the treatment of hypertension to lower blood pressure. The label also says there are no controlled trials demonstrating risk reduction with torsemide.

    Applies to Recipient not specified Patients with edema, and patients with hypertension, as described in the US label of generic torsemide tablets

    Certainty method
    Not assessed
    Limitations
    This claim records what one generic US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label read is a generic product, not the brand label. Contraindications, warnings, interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (4)
    1. Supports openFDA drug label record for torsemide tablets, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (manufacturer Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., application ANDA076894), returned on 2026-11-18. The label text is dated 2023-06-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE
      How it applies
      Label passage quoted in the research quote table (LB-04).
      Retrieved
      Source effective date
      2023-06-30
      Source state
      Current
      Version fingerprint
      81a9f1f71dfafe68937f5c11b1dcb23bd79c5380ca34021244043f8ee68cbbe3
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Supports openFDA drug label record for torsemide tablets, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (manufacturer Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., application ANDA076894), returned on 2026-11-18. The label text is dated 2023-06-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.1 Edema
      How it applies
      Label passage quoted in the research quote table (LB-05).
      Retrieved
      Source effective date
      2023-06-30
      Source state
      Current
      Version fingerprint
      81a9f1f71dfafe68937f5c11b1dcb23bd79c5380ca34021244043f8ee68cbbe3
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    3. Supports openFDA drug label record for torsemide tablets, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (manufacturer Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., application ANDA076894), returned on 2026-11-18. The label text is dated 2023-06-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.2 Hypertension
      How it applies
      Label passage quoted in the research quote table (LB-06, LB-08).
      Retrieved
      Source effective date
      2023-06-30
      Source state
      Current
      Version fingerprint
      81a9f1f71dfafe68937f5c11b1dcb23bd79c5380ca34021244043f8ee68cbbe3
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    4. Background openFDA drug label record for torsemide tablets, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 03fbbb85-4e0f-4f3b-b4b0-87f84cb33d47 (manufacturer Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., application ANDA076894), returned on 2026-11-18. The label text is dated 2023-06-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20230630.
      Retrieved
      Source effective date
      2023-06-30
      Source state
      Current
      Version fingerprint
      81a9f1f71dfafe68937f5c11b1dcb23bd79c5380ca34021244043f8ee68cbbe3
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Record details

Record id
cardio:torsemide
Content hash
ff9272cac6e764e7bd950b575ab06aaccca96ad16f374ee08d2a23dabe99922b